Metabotropic glutamate receptor antagonist reduces craving for cocaine and alcohol
Researchers from four countries have reported success in a phase II clinical trial of the metabotropic glutamate receptor antagonist mavoglurant in cocaine use disorder. Participants used significantly less cocaine while taking it…